Evidence map›Paper›PMID 33822071›Full record

ArticleJAMA network open2021

Trends in Female Authorship in Major Journals of 3 Oncology Disciplines, 2002-2018.

Anirudh Yalamanchali, Emily S Zhang, Reshma Jagsi

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Variations in Author Gender in Obstetrics Disease Prevalence Literature: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  2. Gender disparities in academic radiation oncology research: A narrative review.Clinical and translational radiation oncology · 2027
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anirudh YalamanchaliMedicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Emily S ZhangHead and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Reshma JagsiDepartment of Radiation Oncology, University of Michigan, Ann Arbor.
Cleveland Clinic · USUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Gender disparity exists among authors of the oncology literature. Objective: To quantify trends in authorship by gender within a comprehensive data set of Medline-indexed oncology articles in medical journals with high impact factors. Design, Setting, and Participants: This cross-sectional study used Medline citations to examine archives of research journals from 3 disciplines in the oncology literature. Authors from all oncology-related articles with Medical Subject Headings terms assigned from 2002 to 2018 from 13 general oncology/medicine, radiation oncology, and surgical journals were included for analysis, encompassing clinical trials, observational studies (excluding case reports), reviews, systematic reviews, meta-analyses, and all other published articles. Data were analyzed between April and May 2020. Exposures: Authors were assigned genders based on societal naming norms via third-party gender identification service Gender-API.com. This assignment was internally validated based on manually obtained publicly available data on the internet. Main Outcomes and Measures: Trend in female authorship over time while considering journal type, authorship position, and article type. Results: A total of 420 526 authors from 58 368 articles were found, of which 400 945 were assigned a gender based on their name. In total, 29.5% (95% CI, 29.4%-29.6%) of authors were identified as female, rising from 25.5% (95% CI, 24.7%-26.3%) in 2002 to 31.7% (95% CI, 31.2%-32.3%) in 2018. Each subgroup of primary article type by journal type saw a rise in female authorship over the studied period. For primary articles, last authors were less likely to be women than first authors, regardless of journal type, year, and primary article type (eg, general oncology: odds ratio [OR], 0.60; 95% CI, 0.52-0.69). For general oncology articles, women were less likely to be authors of clinical trials at each authorship position than authors at that respective position for observational studies (first, second, and last authors: OR, 0.58; 95% CI, 0.49-0.67; other authors: OR, 0.84; 95% CI, 0.79-0.89). This difference was not seen for radiation oncology or surgical oncology journals. Conclusions and Relevance: This cross-sectional study found that female authorship in oncology research literature has increased. However, there remains a dearth of female senior authors, and the overall rise in female authorship has not kept up with the rise in female oncology faculty.

Indexed as

AuthorshipMedical WritingBiomedical ResearchCross-Sectional StudiesFemaleHumansMedical OncologyPeriodicals as TopicPhysicians, WomenPublishing

Identifiers

PMID33822071
PMCPMC8025110
OpenAlexW3140980502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.